Literature DB >> 22839575

Non-invasive prenatal screening of fetal sex chromosomal abnormalities: perspective of pregnant women.

Tze Kin Lau1, Mei Ki Chan, Pui Shan Salome Lo, Hon Yee Connie Chan, Waisze Kim Chan, Tik Yee Koo, Hoi Yan Joyce Ng, Ritsuko K Pooh.   

Abstract

OBJECTIVE: To study whether pregnant women would like to be informed if sex chromosomal abnormalities (SCA) were suspected with the non-invasive prenatal diagnosis of fetal Down syndrome (the NIFTY) test.
METHODS: Two hundred and one patients carried a singleton pregnancy requesting the NIFTY test were invited to give their preferences if there was suspicion of SCA by the NIFTY test.
RESULTS: Over 93.5% were ethnic Chinese, with a mean age of 36. Prior Down screening was positive in 66 (32.8%). Over 50% of subjects considered SCA to be better in terms of disability compared to Down syndrome, and only 5.2% considered SCA to be worse. Yet, the majority (198, 98.5%) indicated that they wanted to be informed if there was suspicion of SCA. Of whom 34.8% would have an amniocentesis for confirmation, while 57.1% were not certain, indicating the possibility of accepting these conditions.
CONCLUSION: Besides screening Down syndrome by NIFTY, most pregnant women would also like to be informed if there was suspicion of SCA. Those screened positive should be counseled by those with experience in genetics to avoid unnecessary pregnancy termination.

Entities:  

Mesh:

Year:  2012        PMID: 22839575     DOI: 10.3109/14767058.2012.712569

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  7 in total

Review 1.  Recent advances in the prenatal interrogation of the human fetal genome.

Authors:  Lisa Hui; Diana W Bianchi
Journal:  Trends Genet       Date:  2012-11-15       Impact factor: 11.639

2.  Knowledge and attitude of pregnant women in the Kingdom of Saudi Arabia toward Noninvasive prenatal testing: A single center study.

Authors:  Maaged A Akiel; Mohamud S Mohamud; Emad M Masuadi; Hassan S Alamri
Journal:  Mol Genet Genomic Med       Date:  2022-04-28       Impact factor: 2.473

3.  Motivations for undertaking DNA sequencing-based non-invasive prenatal testing for fetal aneuploidy: a qualitative study with early adopter patients in Hong Kong.

Authors:  Huso Yi; Nina Hallowell; Sian Griffiths; Tak Yeung Leung
Journal:  PLoS One       Date:  2013-11-27       Impact factor: 3.240

4.  Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.

Authors:  Wybo Dondorp; Guido de Wert; Yvonne Bombard; Diana W Bianchi; Carsten Bergmann; Pascal Borry; Lyn S Chitty; Florence Fellmann; Francesca Forzano; Alison Hall; Lidewij Henneman; Heidi C Howard; Anneke Lucassen; Kelly Ormond; Borut Peterlin; Dragica Radojkovic; Wolf Rogowski; Maria Soller; Aad Tibben; Lisbeth Tranebjærg; Carla G van El; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

5.  Online direct-to-consumer messages about non-invasive prenatal genetic testing.

Authors:  Ruth M Farrell; Patricia K Agatisa; MaryBeth Mercer; Marissa B Coleridge
Journal:  Reprod Biomed Soc Online       Date:  2016-03-10

6.  The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy.

Authors:  Herb Brar; Eric Wang; Craig Struble; Thomas J Musci; Mary E Norton
Journal:  J Matern Fetal Neonatal Med       Date:  2012-09-12

7.  Limits to the scope of non-invasive prenatal testing (NIPT): an analysis of the international ethical framework for prenatal screening and an interview study with Dutch professionals.

Authors:  A Kater-Kuipers; E M Bunnik; I D de Beaufort; R J H Galjaard
Journal:  BMC Pregnancy Childbirth       Date:  2018-10-19       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.